Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation

H. C. Schouten, Philip Jay Bierman, W. P. Vaughan, A. Kessinger, Julie Marie Vose, D. D. Weisenburger, James Olen Armitage

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Patients with disseminated follicular non-Hodgkin's lymphoma (NHL) are only occasionally cured with standard chemotherapy regimens. Although most of these tumors are initially responsive to chemotherapy, in 40% to 70% of patients the lymphoma wil eventually transform to an NHL of higher grade malignancy and a poorer prognosis. We treated 18 patients having an original diagnosis of follicular NHL with high-dose therapy and autologous bone marrow transplantation. The lymphomas of 10 of the patients had already undergone histologic transformation and eight still had a follicular histologic pattern. The former group had been followed for a longer time from the diagnosis of NHL and had been more extensively treated with conventional chemotherapy regimens. All eight patients with follicular NHL at the time of transplantation are alive for 246+ to 1,804+ days and seven of the patients are in complete remission. In contrast, of the 10 patients in histologic transformation only 1 is alive and in CR. This reflects the inability of these patients to tolerate the high-dose chemotherapy and myelosuppression as well as resistance of their lymphoma to this therapy. This difference in survival between the two groups was high significant (P = .002). We conclude that the outcome of patients with follicular NHL transplanted early before histologic transformation is better than those who are transplanted later in the course of their illness. Because of the relapsing behavior of follicular NHL, a longer follow-up is necessary to prove any impact on the natural history of the disease.

Original languageEnglish (US)
Pages (from-to)2579-2584
Number of pages6
JournalBlood
Volume74
Issue number7
StatePublished - Jan 1 1989

Fingerprint

Follicular Lymphoma
Chemotherapy
Autologous Transplantation
Bone Marrow Transplantation
Non-Hodgkin's Lymphoma
Bone
Drug Therapy
Lymphoma
Tumors
Neoplasms
Transplantation
Survival

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. / Schouten, H. C.; Bierman, Philip Jay; Vaughan, W. P.; Kessinger, A.; Vose, Julie Marie; Weisenburger, D. D.; Armitage, James Olen.

In: Blood, Vol. 74, No. 7, 01.01.1989, p. 2579-2584.

Research output: Contribution to journalArticle

@article{e2045341862d44d2b5db29f53b8c69af,
title = "Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation",
abstract = "Patients with disseminated follicular non-Hodgkin's lymphoma (NHL) are only occasionally cured with standard chemotherapy regimens. Although most of these tumors are initially responsive to chemotherapy, in 40{\%} to 70{\%} of patients the lymphoma wil eventually transform to an NHL of higher grade malignancy and a poorer prognosis. We treated 18 patients having an original diagnosis of follicular NHL with high-dose therapy and autologous bone marrow transplantation. The lymphomas of 10 of the patients had already undergone histologic transformation and eight still had a follicular histologic pattern. The former group had been followed for a longer time from the diagnosis of NHL and had been more extensively treated with conventional chemotherapy regimens. All eight patients with follicular NHL at the time of transplantation are alive for 246+ to 1,804+ days and seven of the patients are in complete remission. In contrast, of the 10 patients in histologic transformation only 1 is alive and in CR. This reflects the inability of these patients to tolerate the high-dose chemotherapy and myelosuppression as well as resistance of their lymphoma to this therapy. This difference in survival between the two groups was high significant (P = .002). We conclude that the outcome of patients with follicular NHL transplanted early before histologic transformation is better than those who are transplanted later in the course of their illness. Because of the relapsing behavior of follicular NHL, a longer follow-up is necessary to prove any impact on the natural history of the disease.",
author = "Schouten, {H. C.} and Bierman, {Philip Jay} and Vaughan, {W. P.} and A. Kessinger and Vose, {Julie Marie} and Weisenburger, {D. D.} and Armitage, {James Olen}",
year = "1989",
month = "1",
day = "1",
language = "English (US)",
volume = "74",
pages = "2579--2584",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "7",

}

TY - JOUR

T1 - Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation

AU - Schouten, H. C.

AU - Bierman, Philip Jay

AU - Vaughan, W. P.

AU - Kessinger, A.

AU - Vose, Julie Marie

AU - Weisenburger, D. D.

AU - Armitage, James Olen

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Patients with disseminated follicular non-Hodgkin's lymphoma (NHL) are only occasionally cured with standard chemotherapy regimens. Although most of these tumors are initially responsive to chemotherapy, in 40% to 70% of patients the lymphoma wil eventually transform to an NHL of higher grade malignancy and a poorer prognosis. We treated 18 patients having an original diagnosis of follicular NHL with high-dose therapy and autologous bone marrow transplantation. The lymphomas of 10 of the patients had already undergone histologic transformation and eight still had a follicular histologic pattern. The former group had been followed for a longer time from the diagnosis of NHL and had been more extensively treated with conventional chemotherapy regimens. All eight patients with follicular NHL at the time of transplantation are alive for 246+ to 1,804+ days and seven of the patients are in complete remission. In contrast, of the 10 patients in histologic transformation only 1 is alive and in CR. This reflects the inability of these patients to tolerate the high-dose chemotherapy and myelosuppression as well as resistance of their lymphoma to this therapy. This difference in survival between the two groups was high significant (P = .002). We conclude that the outcome of patients with follicular NHL transplanted early before histologic transformation is better than those who are transplanted later in the course of their illness. Because of the relapsing behavior of follicular NHL, a longer follow-up is necessary to prove any impact on the natural history of the disease.

AB - Patients with disseminated follicular non-Hodgkin's lymphoma (NHL) are only occasionally cured with standard chemotherapy regimens. Although most of these tumors are initially responsive to chemotherapy, in 40% to 70% of patients the lymphoma wil eventually transform to an NHL of higher grade malignancy and a poorer prognosis. We treated 18 patients having an original diagnosis of follicular NHL with high-dose therapy and autologous bone marrow transplantation. The lymphomas of 10 of the patients had already undergone histologic transformation and eight still had a follicular histologic pattern. The former group had been followed for a longer time from the diagnosis of NHL and had been more extensively treated with conventional chemotherapy regimens. All eight patients with follicular NHL at the time of transplantation are alive for 246+ to 1,804+ days and seven of the patients are in complete remission. In contrast, of the 10 patients in histologic transformation only 1 is alive and in CR. This reflects the inability of these patients to tolerate the high-dose chemotherapy and myelosuppression as well as resistance of their lymphoma to this therapy. This difference in survival between the two groups was high significant (P = .002). We conclude that the outcome of patients with follicular NHL transplanted early before histologic transformation is better than those who are transplanted later in the course of their illness. Because of the relapsing behavior of follicular NHL, a longer follow-up is necessary to prove any impact on the natural history of the disease.

UR - http://www.scopus.com/inward/record.url?scp=0024418979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024418979&partnerID=8YFLogxK

M3 - Article

C2 - 2804380

AN - SCOPUS:0024418979

VL - 74

SP - 2579

EP - 2584

JO - Blood

JF - Blood

SN - 0006-4971

IS - 7

ER -